Huvepharma® announces FDA-approval for cattle feed additive Optigrid® 45 (ractopamine hydrochloride Type A medicated article)
Global animal health company
Huvepharma® has received FDA-approval for Optigrid® 45, a
feed additive used to promote weight gain and improve feed efficiency in
finishing feedlot cattle.Optigrid® 45, which
is comprised of the active ingredient ractopamine hydrochloride, is a
bio-equivalent product to Optaflexx® and can be fed as a complete
feed or top dress feed to cattle fed in confinement for slaughter during the
last 28 to 48 days on feed prior to harvest. When fed as a complete feed,
ractopamine hydrochloride can also promote increased carcass leanness.
“In today’s challenging world with the
continued need for efficiency in beef production, we are pleased to bring further
medicated feed additive options such as Optigrid® 45 to the cattle industry,” says Glen Wilkinson, president
of Huvepharma, Inc. (U.S.). Wilkinson points out
that as an FDA-approved bio-equivalent, Optigrid® 45 provides the
same benefits of dosage, chemical identity, potency, quality, and safety
to the existing ractopamine hydrochloride brand.
Wilkinson adds, “Optigrid® 45 adds
another choice from Huvepharma’s expanding product line and is a continued
example of our commitment to bring our core strength in medicated feed
additives to the U.S. animal food producing industry. Huvepharma’s product
development, regulatory, and sales teams are dedicated to providing effective
and essential animal health products to the livestock industry.”
Huvepharma received FDA approval for Monovet®
90 (monensin Type A medicated article) – a bio-equivalent to Rumensin – in July
2019, and has offered animal health products for poultry, swine and cattle in
the U.S. since 2005.
Throughout the U.S., Huvepharma is focused on building
partnerships with industry customers by offering high quality products and
unparalleled customer service. For more
information, please contact your Huvepharma sales representative and/or
Huvepharma’s Customer Service team at 877-994-4883 or visit www.huvepharma.us.
Huvepharma is a global pharmaceutical company with a focus on developing, manufacturing and marketing human and animal health products. A privately-owned company headquartered in Sofia, Bulgaria, Huvepharma’s U.S. headquarters are located in Peachtree City, GA.
Huvepharma is a registered trademark of Huvepharma EOOD.
Optaflexx and Rumensin are registered trademarks of Elanco US Inc.